Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis
Pinto, A. C. P. N.; Rocha, A. P.; Milby, K. M. M.; Rocha Filho, C. R.; Reis, F. S. A.; Carvas Junior, N.; Civile, V. T.; Santos, R. R. P.; Trevisani, G. F. M.; Ferla, L. J.; Ramalho, G. S.; Puga, M. E. S.; Trevisani, V. F. M.; Atallah, A. N.
Show abstract
CONTEXT AND OBJECTIVECoronavirus disease 2019 (COVID-19) has emerged in China in December 2019 and rapidly spread. Although extraordinary efforts have been made on research regarding pharmacological interventions, none have proven effective. This is the protocol for a rapid living systematic review that aims to compare the effectiveness and safety of different pharmacological interventions for the treatment of COVID-19. METHODSrapid living systematic review methodology with Network Meta-Analysis following the recommendations of Cochrane Handbook. We will include randomized controlled trials (RCT) and quasi-RCTs that evaluate single and/or combined pharmacological interventions at any dose for the treatment of COVID-19. We will search PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), LILACS, Scopus and SciELO to identify potentially eligible studies. No language restrictions will be used in the selection. We will perform the critical appraisal of included studies with the Risk of Bias tool and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review 95%
- Evidence-Based, Cost-Effective Interventions To Suppress The COVID-19 Pandemic: A Systematic Review 94%
- To Include or Not to Include? A prescription from the pharmacy on how to use active learning assisted screening in systematic reviews 91%
Similar papers in this journal
- Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials 94%
- The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research 94%
- Efficacy and safety of acupuncture for postpartum hypogalactia: Protocol for a systematic review and meta-analysis 93%
Similar papers in this journal
- Modelling the impact of behavioural interventions during pandemics: A systematic review 95%
- Efficacy of Acupuncture on Lower Limb Motor Dysfunction Following Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 94%
- Protocol for the systematic review of the Pneumocystis jirovecii -associated pneumonia in non-HIV immunocompromised patients 93%
Similar papers in this journal
- Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining methodological quality 94%
- Bias as a source of inconsistency in ivermectin trials for COVID-19: A systematic review 94%
- The impact of retracted randomised controlled trials on systematic reviews and clinical practice guidelines: a meta-epidemiological study 94%
Similar papers in this journal
- Nosocomial Infections Among Patients with COVID-19, SARS and MERS: A Rapid Review and Meta-Analysis 90%
- Application of Telemedicine During the Coronavirus Disease Epidemics: A Rapid Review and Meta-Analysis 89%
- Chest Computed Tomography for the Diagnosis of Patients with Coronavirus Disease 2019 (COVID-19): A Rapid Review and Meta-Analysis 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.